TIMOTHY E. MORRIS - 20 Jun 2024 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AQST	Stock Option (right to purchase)	Award	$0	+38,000		$0.000000	38,000	20 Jun 2024	Common Stock	38,000	$2.50	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares underlying the options vest as follows: 100% of the underlying shares vest June 25, 2025, subject to Mr. Morris' continuous service with the Issuer from the grant date through the applicable vesting date.